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ABSTRACT: We have developed a novel, all-electronic biosensor for opioids that
consists of an engineered μ-opioid receptor protein, with high binding aﬃnity for
opioids, chemically bonded to a graphene ﬁeld-eﬀect transistor to read out ligand
binding. A variant of the receptor protein that provided chemical recognition was
computationally redesigned to enhance its solubility and stability in an aqueous
environment. A shadow mask process was developed to fabricate arrays of hundreds of
graphene transistors with average mobility of ∼1500 cm2 V−1 s−1 and yield exceeding
98%. The biosensor exhibits high sensitivity and selectivity for the target naltrexone, an
opioid receptor antagonist, with a detection limit of 10 pg/mL.
KEYWORDS: Graphene, biosensor, ﬁeld eﬀect transistor, μ-opioid receptor, computational protein design
Graphene ﬁeld eﬀect transistors (GFETs) hold tremendouspromise for use as biosensor transduction elements due
to their high carrier mobility and low noise.1,2 There is a need
for scalable, reproducible fabrication of GFET arrays that
maintain the high graphene mobility, which can be signiﬁcantly
degraded3−6 due to contamination by conventional lithographic
processing.7,8 It is also desirable to develop approaches where a
biological chemical recognition element, e.g., a transmembrane
G-protein coupled receptor, is redesigned for optimized
integration with nanotechnology while retaining the protein’s
native structure, sensitivity, and selectivity. We developed a
class of opioid biosensors that integrates high quality GFETs
for transduction of ligand binding with a computationally
designed water-soluble variant of the human μ-opioid receptor
that marries functionality of the parent membrane protein with
superior properties for production and handling. The
fabrication method is scalable with high yield, and sensors
exhibit high sensitivity and speciﬁcity for the target. The
approach is applicable to a variety of engineered proteins. The
work represents progress toward enhanced methodologies for
detection of small molecules at pg/mL concentrations, precise
monitoring of administration of such molecules, and high-
throughput testing of the aﬃnities of pharmaceutical
compounds for proteins of interest with direct electronic
readout.
Large-area graphene grown by chemical vapor deposition
(CVD) is appropriate for scalable integration of graphene
devices. Care must be taken to avoid lithographic contaminants,
which strongly inﬂuence sensor responses.9 To this end, GFET
fabrication was based on an approach where graphene is
patterned during the transfer process rather than by post-
transfer photolithography. Figure 1a is a schematic of the
process. Gold lines separated by ∼150 μm wide parallel strips
were deposited through a mechanical mask onto a graphene
layer on its copper growth substrate (Figure 1b). When a
“bubbling” method transfer10 was performed, graphene covered
by gold remained pinned on the copper foil, while uncovered
regions were transferred onto an oxidized Si wafer with
prefabricated source and drain contacts (Figure 1c). Though
limited to graphene “ribbon” widths greater than ∼100 μm, the
process enabled parallel fabrication of hundreds of GFETs, with
excellent reproducibility. To quantify GFET quality, hundreds
of devices were fabricated and characterized by electrical
transport and Raman spectroscopy. The average mobility, μ,
and Dirac voltage, VD, for 212 devices were μ = 1496 ± 567
cm2 V−1 s−1 and VD = 15.0 ± 5.3 V (Figure 2b,c). Raman
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spectroscopy of GFET channels (Figure S1 of the Supporting
Information) revealed D/G intensity ratio less than 0.03,
indicative of a low defect density, and 2D/G intensity ratio of
∼1.5, typical of monolayer graphene.11
G protein-coupled receptors (GPCRs) are a family of
transmembrane proteins involved in activating intracellular
signal transduction pathways.12 GPCRs bind a variety of target
ligands, from small molecules to large proteins. They are
involved in the transmission pathways of numerous diseases
and are the target of more than 40% of modern
pharmaceuticals.13 The μ-opioid receptor (MUR) is a GPCR
involved in pain and reward signaling pathways with high
binding aﬃnities for opioids, e.g., β-endorphin, heroin,
morphine, hydrocodone, and fentanyl.14 Generally, GPCRs
are unstable when removed from their hydrophobic membrane
environment, resulting in denaturation, loss of functionality,
and aggregation. Moreover, high-yield heterologous expression
and eﬃcient puriﬁcation of GPCRs remain challenging.
Exterior amino acid residues of GPCRs in the transmembrane
region are largely hydrophobic, which can impede expression
and isolation. By computationally redesigning these residues to
be hydrophilic, GPCRs and other membrane proteins can be
identiﬁed that are expressed in large quantity in E. coli, are
structurally stable outside of a membrane, and exhibit
functionally related properties.15−19 A designed, water-soluble
variant of human MUR can be expressed in E. coli and retains
opioid aﬃnities comparable to the wild-type receptor.19 No
membranes or membrane surrogates are required. The
combination of these advances in obtaining functional forms
of receptor proteins (GPCRs) that can be manipulated outside
biomembranes and the GFET fabrication procedure outlined
above opens a route to highly sensitive nanosensors, where the
recognition element is essentially the biological receptor
protein.
In this work, we demonstrated a bioelectronic GFET
nanosensor based on a solubilized MUR variant, and we used
it to detect naltrexone, an opioid receptor antagonist, at
Figure 1. Fabrication process for high quality graphene ﬁeld eﬀect
transistors (GFETs). (a) Schematic of the fabrication process (see
Methods and main text for description). (b) Copper foil shadow mask
placed in contact with graphene on catalytic copper foil. Narrow
regions of graphene protected by the mask are eventually transferred
onto source and drain contacts to form the transistor channel. (c)
Example of a GFET device made by transferring graphene stripes onto
prefabricated electrodes and photograph of an array of 192 GFET
devices, with ∼99.5% device yield.
Figure 2. Performance characteristics of graphene ﬁeld eﬀect
transistors (GFETs). (a) Representative set of 50 I−Vg curves,
demonstrating the uniformity of the electrical characteristics. (b, c)
Histograms of GFET mobility and Dirac voltage along with Gaussian
ﬁts (black curves).
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concentrations as low as 10 pg/mL with excellent speciﬁcity.
The graphene functionalization scheme presented here can be
readily applied to other proteins; the work reveals a new family
of biosensors that combine the functional properties of GPCRs
with the environmental sensitivity of graphene for tailored and
targeted chemical detection.
GFET arrays were functionalized with water-soluble MUR
using a methodology based on our earlier experiments with
exfoliated graphene.20 To our knowledge, this is the ﬁrst
application of this approach to devices based on large-area
graphene. The process began with incubation in a solution of 4-
carboxybenzenediazonium tetraﬂuoroborate, which produces
carboxylic acid sites on the graphene that were then activated
and stabilized with 1-ethyl-3-[3-(dimethylamino)propyl]-
carbodiimide hydrochloride/sulfo-N hydroxysuccinimide
(EDC/s-NHS) in MES buﬀer. Incubation in a buﬀer with the
water-soluble MUR led to covalent attachment of the designed
MUR and the graphene (see Methods for further details). To
measure the sensor response, a solution containing a known
concentration of naltrexone in buﬀer was delivered to the
sensor and allowed to react for 40 min before being rinsed with
DI water and blown dry.
Devices were characterized through the functionalization
process by Raman spectroscopy of the GFET channel and
atomic force microscopy (AFM). Raman spectra of GFETs
after incubation in diazonium salt solution (Figure 3a)
displayed strong increases in the D (“disorder”) peak ca.
1360 cm−1, consistent with formation of sp3-hybridized sites.21
AFM showed enhanced binding of water-soluble MUR to the
graphene sheet compared to the SiO2 substrate and veriﬁed the
eﬀectiveness of the attachment chemistry, e.g., 128 proteins
bound to 27 μm2 of graphene (4.7/μm2) and ﬁve protein-sized
features in an area of 9 μm2 of substrate (0.55/μm2) in Figure
3b. AFM line scans were used to create a height histogram for
immobilized proteins (Figure 3c), which showed a primary
maximum at ∼4 nm, consistent with the 46 kDa mass and
structure of MUR;22 secondary maxima at 8 and 12 nm were
attributed to protein aggregates. To check that proteins were
bound to the graphene covalently rather than by nonspeciﬁc
adsorption, the functionalization procedure was performed with
the diazonium salt step omitted. In this experiment, the density
of nonspeciﬁcally adsorbed protein on both the graphene and
the oxidized silicon substrate was similar to that observed on
the bare substrate in Figure 3b (Figure S2 of the Supporting
Information).
Samples were characterized after each step of functionaliza-
tion chemistry and exposure to naltrexone target by measuring
the source-drain current as a function of back gate voltage (I−
VG characteristic). The Dirac voltage and carrier mobility were
very sensitive to chemical treatment (Figure 4a). After
diazonium treatment, VD increased by 70−90 V, consistent
with the presence of negative charge (carboxylate) near the
GFET channel.23 Additionally, mobility was found to be
reduced by ∼50%, which was ascribed to carrier scattering by
sp3-hybridized sites created on the graphene surface. EDC/s-
NHS treatment decreased the Dirac voltage by ∼20 V, likely
due to neutralization of carboxylate by the s-NHS ester. While
MUR attachment did not signiﬁcantly shift the Dirac point,
there was an increase in the device mobility of ∼10%.
For naltrexone response experiments, each device was
exposed to a single concentration to avoid sample contami-
nation across trials; 15−30 devices were tested against each
concentration. A reproducible, concentration-dependent in-
crease in VD was observed (Figure 4e). Device-to-device scatter
in this signal parameter appeared to be random and
uncorrelated with other device properties, i.e., the Dirac voltage
and carrier mobility. The data are well ﬁt by a model adapted
from the Hill−Langmuir equation that describes equilibrium
binding of a ligand by a receptor.24 The model includes a term
that reﬂects naltrexone binding and an oﬀset parameter Z to
account for ΔVD observed in the absence of naltrexone:
Δ =
+
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Here A is the maximum response with all binding sites
occupied, c the concentration of the applied naltrexone
solution, Ka an eﬀective dissociation constant that describes
the naltrexone concentration that produces half occupation of
μ-receptors, n the Hill coeﬃcient, and Z the oﬀset parameter.
The best ﬁt to the data yielded values A = 9.26 ± 0.24 V, Ka =
7.8 ± 1.6 ng/mL, n = 0.41 ± 0.03, and Z = 0.11 ± 0.03 V.
During the curve ﬁtting process, A was constrained to be in the
range of 8.5−10 V based on observed responses, and the other
parameters were unconstrained.
The best ﬁt value of the oﬀset parameter Z = 0.11 ± 0.03 V
agrees with measured responses of devices exposed to pure
Figure 3. Results of characterization by Raman spectroscopy and
atomic force microscopy (AFM). (a) Raman spectrum of graphene
before (red data) and after (black data) exposure to diazonium salt
solution. The strongly enhanced D-band (near 1360 cm−1) after
diazonium treatment indicates the formation of carboxybenzene sites
on the graphene surface. (b) AFM image of soluble μ-receptor
proteins (white dots) decorating the graphene surface. The density of
protein molecules is approximately 10 times greater on the graphene
as compared to the SiO2 substrate. Scale bar is 2 μm. (c) Histogram of
the heights of proteins indicating that the 46 kDa μ-receptor monomer
is ∼4 nm tall on the surface, with dimers and trimers of 8 and 12 nm,
respectively.
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buﬀer (Z = 0.04 ± 0.38 V). The best ﬁt value of Ka = 7.8 ± 1.6
ng/mL for the soluble MUR is within the expected range 1.5−
100 nM, as reported previously for both the designed and wild-
type MUR.19,25 Under the reasonable, but not yet tested,
assumption of a linear relationship between GFET sensor
response and analyte binding, the best ﬁt value n = 0.41 ± 0.03
suggests negative cooperativity in the binding of naltrexone to
the GFET biosensor that may be due to protein−protein
interactions upon binding or increased charge carrier scattering
with increased ligand binding. Similar behavior (n < 1) was
observed in biosensors based on protein-functionalized carbon
nanotube transistors.26 These results demonstrate that a
collection of 15−30 GFET devices functionalized with the
water-soluble MUR can distinguish between pure buﬀer (ΔVD
= 0.04 ± 0.38 V) and a solution containing naltrexone at a
concentration of 10 pg/mL (3 pM; ΔVD = 0.93 ± 0.34 V).
Control experiments were conducted on 12−20 GFET
devices per condition to verify that sensor responses reﬂected
speciﬁc binding of naltrexone to the soluble MUR. Results are
summarized in Table 1. Devices functionalized with water-
soluble MUR were exposed to pure buﬀer with no naltrexone;
the sensor response was consistent with zero (ΔVD = 0.04 ±
0.38 V). A benzodiazepine receptor antagonist compound,
ﬂumazenil, at a concentration of 10 μg/mL was delivered to the
sensors under conditions identical to the naltrexone experi-
ments. Flumazenil is known not to bind to μ-receptors,27 and
indeed we did not observe a statistically signiﬁcant shift in the
Dirac voltage (ΔVD = −0.23 ± 0.43 V). Experiments were
performed where (i) the μ-receptor addition step was omitted
and (ii) where the μ-receptor was replaced with an antibody
fragment, anti-HER2 scFv. Sensor responses were measured
upon exposure to naltrexone at 10 μg/mL, the highest
concentration tested. Again, the response was consistent with
zero, implying that the MUR was necessary to bind naltrexone
and produce the characteristic ΔVD. These experiments provide
strong evidence that sensor responses derived from speciﬁc
interactions between the water-soluble MUR and the opioid
receptor antagonist naltrexone.
The proposed mechanism for the concentration-dependent
ΔVD is a conformational change in the variant MUR upon
naltrexone binding, as observed for other GPCRs,28 which
alters the electrostatic environment of the GFET (“chemical
gating”). A similar chemical gating response has been
demonstrated in carbon nanotube FETs.23 The Raman spectra
of GFETs were also sensitive to the presence and concentration
of naltrexone (Figures S3, S4 and Tables S1, S2 in the
Supporting Information), consistent with the fact that Raman
spectra are also sensitive to chemical gating.29,30 Although a
precise quantitative understanding of the mechanism remains
to be developed, we believe that the methods presented here
could be generalized to create a new generation of
manufacturable graphene-based biosensors with the highly
sensitive and speciﬁc chemical recognition characteristic of
GPCRs.
In conclusion, we demonstrated a novel biosensor based on
arrays of graphene FETs functionalized with a designed, water-
soluble μ-receptor protein. Scalable fabrication methods were
used to produce large arrays of high quality graphene transistors
as evidenced by electronic and Raman characterization. The
devices enabled detection of the opioid receptor antagonist
naltrexone at concentrations as low as 10 pg/mL. Measured
sensor responses over a range of 6 orders of magnitude in
concentration (10 pg/mL to 10 μg/mL) were well ﬁt by a
model based on the Hill−Langmuir binding equation. Control
experiments veriﬁed that the sensor response derived from
speciﬁc binding of the μ-receptor to naltrexone, indicating that
the water-soluble MUR maintains its biologically active analyte
binding conﬁguration while covalently bound to graphene. By
functionalizing such GFET arrays with multiple selected
proteins, it should be possible to create a single integrated
Figure 4. Current−gate voltage (I−VG) characteristic measurements
after chemical treatment and naltrexone exposure. (a) I−VG plots after
successive functionalization steps. After functionalization with the
solubilized μ-receptor, exposure to a solution of 1 μg/mL naltrexone in
buﬀer leads to an increase in the Dirac voltage of 8.5 V (green curve to
orange curve). (b) Magniﬁed view of the Dirac voltage increase. (c) I−
VG plots after successive functionalization steps with the device now
exposed to a solution of 100 pg/mL naltrexone in buﬀer (green curve
to orange curve). The Dirac voltage increase is 1.8 V. (d) Magniﬁed
view of this shift in the Dirac voltage. (e) Sensor response (increase in
Dirac voltage) as a function of naltrexone concentration. The signal is
still discernible from the bare buﬀer response at 10 pg/mL naltrexone.
The data are ﬁt to a modiﬁed Hill−Langmuir equation (black curve;
see main text for details). The buﬀer response (green line) is deﬁned
as the average response plus one standard error of 15 GFETs exposed
to pure buﬀer without protein.
Table 1. Summary of Control Experiments Performed To
Test the Conclusion That Sensor Responses Derive from
Speciﬁc Binding of Naltrexone to the Mu Receptor Proteina
sample analyte
av Dirac voltage
shift (V)
MUR-GFET buﬀer with no naltrexone 0.04 ± 0.38
MUR-GFET ﬂumazenil at 10 μg/mL −0.23 ± 0.43
MUR omitted naltrexone at 10 μg/mL −0.25 ± 0.35
anti-HER2 scfv-GFET naltrexone at 10 μg/mL −0.31 ± 0.48
MUR-GFET naltrexone at 10 μg/mL 8.78 ± 0.55
aQuoted errors are the standard error of the mean.
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biosensor platform for detection of a large number of analytes.
Nanoelectronic interrogation of proteins while they are
subjected to new pharmaceutical treatments could perhaps
serve as a sensitive readout for drug discovery applications.
Methods. Growth of Large-Area Graphene by Chemical
Vapor Deposition (CVD). Continuous (monolayer) graphene
sheets were grown on copper foil by atmospheric pressure
CVD according to methods we published previously.31 Brieﬂy,
copper foil (Alfa Aesar Item #46365) was placed in a CVD tube
furnace and heated to 1057 °C under argon and hydrogen
forming gas. Immediately upon reaching 1057 °C, methane was
introduced to the furnace chamber, and the graphene growth
proceeded for 30 min. The furnace was then slid downstream
while holding the quartz tube ﬁxed so that the copper foil was
outside the furnace heating elements, enabling rapid cooling of
the copper foil necessary for monolayer graphene formation.
Once the chamber cooled to 100 °C, the foil was removed from
the furnace.
Fabrication of GFETs by Patterned Transfer. After
graphene synthesis, the copper growth substrate was placed
into close contact with a stripe-patterned mechanical mask and
inserted into a thermal evaporator (Figure 1a). 7 nm Ti/55 nm
Au was deposited on the sample, with the shadow mask
creating parallel strips of graphene that were not covered by
metal (see Figure 1). Poly(methyl methacrylate) (PMMA) was
then spun over the surface of the copper foil/graphene/gold
sample and baked at 100 °C for 2 min. Graphene was then
separated from the copper foil using the electrochemical
“bubble” transfer method. The sample was slowly lowered into
a 0.1 M NaOH solution with a 25 V potential diﬀerence applied
between the copper foil and the solution. Gas bubbles formed
at each electrode, which served to separate the graphene from
the copper foil. However, graphene areas covered by gold were
pinned to the copper foil, and only the uncovered areas were
free to come oﬀ with the PMMA support layer. This approach
enable the transfer of patterned stripes of graphene without the
need for conventional photolithography and without introduc-
ing any additional chemicals which may cause unwanted doping
or contamination. The PMMA/graphene layer was carefully
transferred to two deionized water baths and then placed onto a
Si wafer (300 nm oxide) so that it aligned with prefabricated
electrodes for source and drain contacts. The PMMA was
rinsed oﬀ with acetone, and the devices were annealed in Ar/H2
for 1 h at 200 °C to remove remaining PMMA. Device yield at
this stage typically exceeded 99%, with excellent uniformity.
Water-Soluble Human MUR Engineering, Expression, and
Puriﬁcation. A variant of water-soluble MUR was computa-
tionally designed as described previously, wherein exterior,
transmembrane residues were targeted and redesigned.19 The
engineered variant was expressed and puriﬁed as described
previously without further modiﬁcation.19 Brieﬂy, the synthetic
cDNA encodings of the water-soluble MUR were produced by
GenScript Inc. (Piscataway, NJ). The sequences were
subcloned between the NdeI and XhoI restriction sites of the
expression plasmid pET-28b(+) (EMD/Novagen). This
cloning strategy resulted in placement of a His-tag at the
amino terminus of the protein. E. coli BL21(DE3) cells (EMD/
Novagen) were used for expression. The protein was puriﬁed
using the His-tag and conﬁrmed using mass spectrometry.
Protein Functionalization of GFETs and Exposure to
Naltrexone Target. The ﬁrst step was incubation at 55 °C in
a solution of a carboxylated diazonium salt, 4-carboxybenzene-
diazonium tetraﬂuoroborate (2.0 mg/mL in DI water).
Diazonium salts were synthesized in-house according to a
published protocol.32 Carboxylic acid groups from the
diazonium functionalization were activated and stabilized with
1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide hydrochlor-
ide/sulfo-N-hydroxysuccinimide (EDC/s-NHS) at an EDC
concentration of 9 mg/15 mL MES buﬀer and NHS
concentration of 20 mg/15 mL MES buﬀer. NHS molecules
were displaced by amine groups on the designed MUR protein
(3 μg/mL) in buﬀer (40 μM NaPi/260 μM NaCl/0.00004%
SDS/10 μM 2-ME/pH 7.0) to form a covalent amide bond
between the soluble MUR and the graphene. Finally, an
amount of a known opioid receptor antagonist (naltrexone)
was delivered to the sensor and allowed to react in a humid
environment for 40 min before being rinsed in DI water and
blown dry under nitrogen. The time of 40 min was chosen
based on a calculation that 15 min would be required for
diﬀusion of naltrexone molecules to the sensor surface and to
ensure a binding equilibrium was established at the lowest
concentrations tested.
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